Newsletter | October 24, 2023

10.24.23 -- Navigating The Murky Waters Of Patent Claims Involving AI After Amgen v. Sanofi



Navigating The Murky Waters Of Patent Claims Involving AI After Amgen v. Sanofi

In May 2023, the Supreme Court issued a ruling on the Section 112 enablement requirement for patents in Amgen v. Sanofi. What does this mean for patent claims involving artificial intelligence (AI) going forward? These Haynes Boone attorneys explain.


Predictive Modeling Of Viscosity Behavior Using Artificial Neural Networks

Discover a modeling approach employing artificial neural networks (ANNs) using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

Fundamentals Of Size Exclusion Chromatography

SEC, also known as gel filtration, can be used for preparative and analytical studies of your protein. But how do you know which parameters give you the best resolution of your protein mixture?

Improving Sustainability Via Incineration Reduction And Solvent Recovery

Wastewater incineration reduction and solvent recovery are two sustainable process techniques that can be built into the drug manufacturing workflow to significantly reduce carbon emissions and waste.

Mitigating Risk In Tech Transfer: Insights For Finding The Right Partner

Establishing a relationship with a partner who has the right equipment, scientific expertise, and project management skills is crucial to mitigating risk in tech transfers and, ultimately, controlling costs.


Targeting A Coronavirus Ion Channel Could Yield New Covid-19 Drugs

Saama Signs New Agreement That Will Enable AI-Driven Drug Development

Servier Partners With Owkin To Discover & Develop AI-Driven Precision Therapeutics

ContraFect Announces FDA Clearance Of CF-370 IND Application

Nkarta Receives FDA Clearance Of IND Application For NKX019 In Lupus Nephritis

Catalyst Pharmaceuticals Announces FDA Acceptance Of The sNDA For FIRDAPSE

Wyss Institute At Harvard University Wins BARDA Contract

Antiverse & GlobalBio, Inc. Extend Collab To Advance Antibody Cancer Therapeutics

LCB Enters Worldwide Licensing Agreement With Glycotope For ADC Development

Fighting Antimicrobial Resistance With New Drug Combinations

Yeast Speeds Discovery Of Medicinal Compounds In Plants


Analytical Services: Capabilities And Expertise

Cell Line And Upstream Process Development Services


Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.